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Abstract The hypothesis that the uneven distribution of
bilirubin in the organism, which occurs in hyperbilirubinemia,
could reflect an uneven distribution of bilirubin-binding proteins
was tested by searching for peptides containing the bilirubin-
binding motif identified in bilitranslocase (Battiston et al., 1998).
In the rat, positive proteins bands were found to be present only
in the liver, gastric mucosa and central nervous system. The
electrophoretic mobilities of the positive compounds in the liver
and stomach were identical to that of purified bilitranslocase
(38 kDa). In the brain, on the contrary, two peptides were found
with molecular masses of 79 and 34 kDa, respectively. Their
distribution pattern in the central nervous system was different
for each of them.
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1. Introduction
Recently it was shown that the amino acid sequence
EDSQGQHLSSF, present in the primary structure of bili-
translocase, corresponds to the central part of the bilirubin-
binding site of the carrier [1,2]. The original assumption was
based on the following observations: (a) the sequence in ques-
tion is part of a motif conserved in ancient biliproteins such as
phycocyanins whose prosthetic group is chemically related to
bilirubin and (b) the motif, in phycocyanins, is located in
proximity of the pigment [3]. Subsequently, it was possible
to show directly that the immobilised peptide could e⁄ciently
compete with albumin for bilirubin-binding [4]. In addition, a
sequence-speci¢c antibody directed against the sequence men-
tioned above not only identi¢ed both puri¢ed bilitranslocase
[1] and a single polypeptide with an identical mobility in solu-
bilised plasmamembrane vesicles from rat liver but also inhib-
its the electrogenic sulfobromophthalein transport in this frac-
tion, an activity speci¢c for this translocator [5]. The kinetics
of inhibition are depressed by bilirubin and nicotinate [1]. The
calculated dissociation constants for the bilirubin- and nico-
tinate-bilitranslocase complexes were found to be 2 and
11 nM, respectively. These two values, in the nM range, are
adequate for the function of bilitranslocase, which should be
able to handle a substrate whose free concentration in plasma
is maintained at an extremely low value due to the presence of
serum albumin [6]. Such values, on the other hand, point to a
very high a⁄nity of the sequence in question for unconjugated
bilirubin and suggest the possibility that the motif could be
present also in other proteins potentially endowed with high
a⁄nity bilirubin-binding.
The availability of antibodies directed against the sequence
of interest o¡ered the opportunity to investigate the tissue
distribution of bilitranslocase or, anyway, of proteins with
an identical epitope and thus potentially capable of biliru-
bin-binding. This approach allows us to test the hypothesis
that the tissue distribution pattern of proteins endowed with
the ability to bind the pigment with high a⁄nity (possibly
contributing to its accumulation in certain regions of the or-
ganism) may account for the uneven distribution of the pig-
ment, observed particularly during severe jaundice.
Data presented in this paper show that bilitranslocase (or at
least a protein with identical mobility) is present not only in
the liver but also in the gastric mucosa of the rat. In the
central nervous system, two additional positive protein bands
were found and, on the basis of their electrophoretical mobil-
ity, apparent molecular masses of 79 and 34 kDa was calcu-
lated. None of the two proteins was evenly distributed in the
central nervous system (CNS) and, in addition, each compo-
nent was found to be distributed according to its own pattern.
2. Materials and methods
2.1. Preparation of the biological material
The di¡erent tissues were all homogenised (10%) in 0.25 M sucrose,
0.1 mM ethylenediaminetetraacetic acid (EDTA) using a motor-driven
te£on glass Potter homogeniser. In the case of skeletal muscle, heart
and uterus, sucrose solution was substituted with 0.15 M KCl bu¡ered
with 20 mM Tris-HCl (pH 7.4) and 1 mM EDTA. At the end of the
homogenisation, if necessary, neutralisation was carried out by adding
drops of 1 M Tris base. The homogenates were centrifuged for 15 min
at 5000Ug at 4‡C. The supernatants were again spun down at
105 000Ug for 1 h at the same temperature. The sediments were
resuspended in an appropriate volume of homogenisation medium.
The microsomal fractions obtained as described usually collect at
least 50% of the total plasmamembrane of the cells. In this way, we
restricted our study to membranous material collected in these frac-
tions disregarding nuclear and mitochondrial membranes as well as
soluble proteins.
2.2. Multiple antigen peptide (MAP) generation and antibody
production and puri¢cation
An undecapeptide (EDSQGQHLSSF) corresponding to sequence
65^75 of bilitranslocase [1] was synthesised coupled to an octalysine
core to generate a MAP according to Tam [7]. The chemical synthesis
was generously carried out for us by Prof. Renato Gennaro, Univer-
sity of Udine (Italy). Antibodies against the MAP were obtained in
rabbits. The sequence-speci¢c antibodies were puri¢ed by a⁄nity
0014-5793 / 99 / $20.00 ß 1999 Federation of European Biochemical Societies. All rights reserved.
PII: S 0 0 1 4 - 5 7 9 3 ( 9 9 ) 0 0 7 3 6 - X
*Corresponding author. Fax: (39) (40) 6763691.
E-mail: sottoca@bbcm.univ.trieste.it
Abbreviations: CNS, central nervous system; MAP, multiple antigen
peptide; SDS, sodium dodecyl sulfate; SDS-PAGE, sodium dodecyl
sulfate-polyacrylamide gel electrophoresis; EDTA, ethylenediamine-
tetraacetic acid; TBS, Tris-bu¡ered saline; BSA, bovine serum albu-
min
FEBS 22191 18-6-99
FEBS 22191 FEBS Letters 453 (1999) 351^355
chromatography using A⁄-Gel 10 (Bio-Rad Laboratories, CA, USA)-
coupled MAP (3.5 mg/ml). The elution from the column was carried
out with an acid bu¡er (glycine-HCl, pH 2.5) and immediately neu-
tralised with 1 M Tris pH 8. In order to minimise adsorption to test
tubes, bovine serum albumin (BSA) (1.5 mg/ml) (Sigma, St. Louis,
MO, USA) was added to the puri¢ed antibodies and, after enzyme-
linked immuno adsorbent assay titration, stored at 320‡C.
2.3. Electrophoretic and Western blotting analysis
The post-mitochondrial fractions obtained as described above, rat
liver plasmamembrane vesicles [8] and puri¢ed bilitranslocase [9] were
denatured in 2.5% sodium dodecyl sulfate (SDS) and 5% 2-mercap-
toethanol, boiled for 5 min and separated on a 12% SDS-polyacryl-
amide gel electrophoresis (PAGE) gel. The proteins were electropho-
retically transferred on an Immobilon-polyvinylidene di£uoride
membrane (Millipore, Bedford, MO, USA) according to Gershoni
and Palade [10]. As a primary antibody, a⁄nity chromatography-pu-
ri¢ed anti-MAP antibodies, at the ¢nal concentration of 0.66 Wg IgG/
ml in the blocking bu¡er (Tropix, Bedford, MO, USA), were used.
The incubation was performed overnight at 4‡C, under mild agitation.
The secondary antibody was 1:1000 diluted alkaline phosphatase-
linked anti-rabbit IgG (Sigma, St. Louis, MO, USA). This second
incubation lasted 1 h at room temperature. Extensive washing with
phosphate-bu¡ered saline (75 mM phosphate bu¡er, pH 7.4, 150 mM
NaCl) containing 0.1% Tween 20 and 0.2% I-Block (Tropix, Bedford,
MO, USA) was carried out. After a ¢nal washing in 10 mM dieth-
anolamine bu¡er (pH 10) containing 1 mM MgCl2, the antibody-
binding was detected by the enhanced chemiluminescence technique
using CSPD as substrate (Tropix, Bedford, MO, USA). The light
intensity was determined by exposing X-ray ¢lms (Kodak, Rockester,
NY, USA) to the membranes for 1^5 min.
2.4. Immunochemical microscopy
Tissue ¢xation was carried out with 4% paraformaldehyde in
100 mM phosphate bu¡er (pH 7.4) overnight at 4‡C. The specimens
were washed in several changes of the same phosphate bu¡er and then
dehydrated in a graded series of ethanol solutions before embedding
in para⁄n. 5 Wm thin sections were used for light microscopy and
processed further on microscopy glasses. The specimens were exposed
for 1 h at room temperature to a Tris-bu¡ered saline (TBS) solution
(10 mM Tris-Cl, 120 mM NaCl, pH 7.4) containing 1% BSA (Sigma,
St. Louis, MO, USA) and 20% normal goat serum and then incubated
overnight at 4‡C with a⁄nity chromatography-puri¢ed sequence-spe-
ci¢c antibodies (¢nal concentration of 0.66 Wg IgG/ml) in TBS con-
taining 0.1% Tween 20 (Sigma, St. Louis, MO, USA) and 5% normal
goat serum. The specimens were washed with TBS containing 1%
BSA and incubated for 2 h at room temperature with colloidal gold
(20 nm) conjugated goat anti-rabbit IgG (British BioCell Internation-
al, Cardi¡ Wales, UK) diluted 1:100 in TBS containing 1% normal
goat serum, 5% foetal calf serum, 1% BSA and 0.1% Tween 20. The
specimens were washed in TBS+BSA followed by two washes in dis-
tilled water. Gold particles were enhanced by treatment with a silver
enhancer kit (British BioCell International, Cardi¡ Wales, UK). The
specimens were mounted as such after dehydration.
3. Results
It is well known that a classical microsomal fraction collects
more than 50% of the total plasmamembrane. Such a fraction
could therefore represent a useful material to investigate the
distribution of a plasmamembrane protein in di¡erent tissues.
It was necessary, ¢rst of all, to check that a liver microsomal
preparation was adequate for the detection of bilitranslocase.
Fig. 1 shows the results of an experiment in which erythrocyte
ghosts (negative control) [5], plasmamembrane vesicles and
microsomes from rat liver were subjected to electrophoresis
and Western blotting in comparison with puri¢ed rat liver
bilitranslocase. Clearly, the positivity to the sequence-speci¢c
antibody and the corresponding mobility (around 38 kDa
apparent molecular mass) were the same in all the three pos-
itive samples. It was hence concluded that the sensitivity of
the method was adequate to detect the presence of bilitranslo-
case in a microsomal fraction.
On these grounds, using the same subcellular fraction, we
extended the study to other tissues. Fig. 2 shows that gastric
mucosa gives a positive protein band with a mobility identical
to that of liver bilitranslocase. Conversely, the kidney and
pancreas were devoid of any reactive polypeptide. In the cen-
tral nervous tissue, two immuno-reactive polypeptides were
detected. On the basis of their relative mobility, apparent
molecular masses of 79 and 34 kDa were calculated. The
possibility was considered that the two polypeptides found
represented two di¡erent levels of aggregation of the same
monomer. This was ruled out by the ¢nding that the relative
proportion of the two bands did not change when the same
sample was pre-treated with 6 M urea (lane 6, added for
comparison).
As for gastric mucosa, it should be mentioned that it was
Fig. 1. Western blot of solubilised proteins from erythrocyte ghosts,
plasmamembranes and microsomes from rat liver in comparison
with puri¢ed hepatic bilitranslocase. Experimental conditions: in
lane 1, 2 and 3, 60 Wg of proteins from erythrocyte ghosts, plasma-
membrane vesicles and microsomes was loaded. In lane 4, approxi-
mately 0.5 Wg puri¢ed bilitranslocase was loaded. The electrophore-
sis and Western blot were performed as reported in Section 2.
Fig. 2. Tissue distribution of the bilirubin-binding motif on solubi-
lised proteins of the liver, gastric mucosa, pancreas, kidney cortex
and whole brain post-mitochondrial fractions from rat. Experimen-
tal conditions: all wells were loaded with 60 Wg of SDS-solubilised
microsomal proteins. Lane 1: liver; lane 2: gastric mucosa; lane 3:
pancreas; lane 4: kidney cortex, lane 5: whole brain; lane 6: whole
brain pre-treated with 6 M urea. The electrophoresis and Western
blot were performed as reported in Section 2.
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obtained by mechanical scraping of the lumenal surface of the
stomach and the resulting material is expected to be highly
heterogeneous. A more precise assessment of the cellular type
responsible for the data found could be obtained by immu-
nochemistry. Such an approach showed that the protein tar-
geted by the antibody is con¢ned to epithelial cells (data not
shown). At a high magni¢cation, Fig. 3 shows a number of
secretory cells stained with immuno-gold (A) and the appro-
priate control (B). Most cells gave a positive response
although unstained or poorly stained elements were also
present.
In view of the high level of structural complexity of the
brain and in consideration of the fact that bilirubin tends to
accumulate unevenly in this organ during severe jaundice
[11,12], we thought it was interesting to study the distribution
of the two proteins in di¡erent brain regions. To this aim, the
experiment reported in Fig. 4 was carried out. All the wells
were loaded with the same amount of proteins so that an
approximately quantitative comparison can be done.
Starting from lane 2, where the two polypeptides are virtu-
ally equally abundant, one observes a progressive decrease of
the high molecular mass compound and a mirror image pic-
Fig. 3. Immuno-gold decorated microscopic sections of the rat gastric mucosa. Experimental conditions were as described under Section 2.
(A) phase-contrast light microscopy of secreting gastric mucosal cells after immuno-gold decoration. (B) Control treated under the very same
conditions with the only omission of the primary antibody. Final magni¢cation U1000.
Table 1
Tissue distribution of immuno-reactive peptides containing the bilirubin-binding motif in the rat
Tissue 38 kDa band 34 kDa band 79 kDa band
Liver ++ ^ ^
Kidney cortex ^ ^ ^
Oesophagus mucosa ^ ^ ^
Gastric mucosa ++ ^ ^
Duodenal mucosa ^ ^ ^
Jejunum mucosa ^ ^ ^
Colon mucosa
-Ascending ^ ^ ^
-Transverse ^ ^ ^
-Descending ^ ^ ^
Spleen ^ ^ ^
Lungs ^ ^ ^
Pancreas ^ ^ ^
Skeletal muscle ^ ^ ^
Heart muscle ^ ^ ^
Myometrium ^ ^ ^
Erythrocytes ^ ^ ^
Whole brain ^ + +
-Midbrain ^ ++ +++
-Cerebral hemisphere ^ + ++
-Cerebellar hemisphere ^ + +
-Brain stem ^ ++ +
-Spinal cord ^ ++ +
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ture is obtained for the low molecular mass one. It may there-
fore be concluded that the two immuno-reactive polypeptides
with potential bilirubin-binding ability are unevenly distrib-
uted in the brain but according to di¡erent patterns.
Table 1 summarises the results obtained on a large number
of tissues. Clearly, only liver and stomach showed a positive
polypeptide with a mobility identical to that of isolated bili-
translocase. On the other hand, the other two immuno-re-
sponsive proteins found in the nervous system were absent
in all the other tissues and organs analysed.
4. Discussion
The data presented in this paper show that hepatic bili-
translocase is the only detectable protein in liver membranes
containing the epitope targeted, which was shown to be lo-
cated in the central part of the bilirubin-binding motif of the
carrier [1,2]. Obviously, the data do not rule out the possible
contribution of other proteins in the transport mechanism of
unconjugated bilirubin either from the blood into the cyto-
plasm of the hepatocytes or from the cytoplasm into the bile
[13^19]. Furthermore, it should be remembered that, in this
case, the material analysed consisted of a classical microsomal
fraction and that the experimental design restricted the ¢eld to
the membranes co-sedimented there. As for the positive pro-
tein band found in gastric mucosa, the question remains if we
were indeed dealing with bilitranslocase or else with a di¡er-
ent protein with very similar immunological and electropho-
retic characteristics. The possibility that the carrier could op-
erate also at the gastric level may be understood in
physiological terms, as connected with the hypothetical up-
take of nicotinic acid in the stomach. Such an event could
ensure an e⁄cient uptake of this vitamin in the proximal
portion of the digestive tract, thus avoiding bacterial utilisa-
tion in the lower part of it. This possibility, though hypothet-
ical, is feasible in view of the very high a⁄nity of bilitranslo-
case for nicotinate (Kd = 11 nM) [1].
A point which deserves discussion is the total absence of
bilitranslocase or, anyway, other peptides with an identical
immuno-reactivity in the kidney cortex. We reported in the
past [20] that, in this tissue, bilitranslocase was present and
localised in the basolateral plasmamembrane of proximal tu-
bules. The kinetic characteristics of the carrier described in
that paper were however di¡erent from those described for
hepatic bilitranslocase in that the apparent Km measured
was 3^4 times higher in the kidney. One of the explanations
suggested for this ¢nding at that time was that renal bilitrans-
locase, although largely homologous to the hepatic protein, is
partially di¡erent in its primary structure. The absence of
reactivity with the sequence-speci¢c antibodies seems to sub-
stantiate this view.
The ¢nding that brain contains two di¡erent proteins giving
a positive response to the treatment with the sequence-speci¢c
antibody opens the possibility that in the CNS, two additional
protein components, with a potential bilirubin-binding ability,
are present. For the time being, the identity of the two com-
ponents, as well as their functions, are completely unknown.
The antibody used allows to predict that cross-reacting pro-
teins should contain at least part of the amino acid sequence
present in the MAP used to raise the antibodies. Data banks
searching for this characteristics (PIR 41, SBASE 2.0 and
Swiss-Prot 29) revealed that the receptor for mineral corticoid
expressed in the hippocampus of the rat [21,22] contains the
sequence QHLSSF. The molecular mass of this protein, how-
ever, is reported to be 106.7 kDa. Always, in the rat, a ho-
mology of six consecutive residues (EDSQGQ) is reported for
chromogranin B, expressed in the hypophysis, whose molec-
ular mass is reported to be 77.9 kDa [23].
Looking for functional homologies, oatp, another organic
anion transporting polypeptide, present in liver and kidney
[15], has recently been reported to be present also in the
CNS [24]. The absence, however, of the epitope targeted in
the known sequence of the oatp family [25] would exclude the
possibility for these proteins to be detected by our sequence-
directed antibody.
Immunochemistry using speci¢c antibodies separately di-
rected to the two proteins will provide an insight to the tissue-
and cellular localisation of them and, perhaps, o¡er sugges-
tions to their function.
In perspective, these ¢ndings may acquire relevance in the
human pathology considering that the two polypeptides iden-
ti¢ed here are potentially endowed with a bilirubin-binding
capacity. It is tempting to speculate that the uneven distribu-
tion of unconjugated bilirubin observed in severe hyperbili-
rubinemia [11,12] may be related to the uneven distribution
of the two proteins.
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